DPH.L - Dechra Pharmaceuticals plc
| Previous close | 3,374.00 |
| Open | 3,675.00 |
| Bid | 2,940.00 x 0 |
| Ask | 3,650.00 x 0 |
| Day's range | 3,628.00 - 3,680.00 |
| 52-week range | 31.08 - 3,882.00 |
| Volume | |
| Avg. volume | 1,403,880 |
| Market cap | 4.136B |
| Beta (5Y monthly) | 0.76 |
| PE ratio (TTM) | 100.89 |
| EPS (TTM) | 0.36 |
| Earnings date | 04 Sept 2023 |
| Forward dividend & yield | 0.45 (1.35%) |
| Ex-dividend date | 09 Mar 2023 |
| 1y target est | 3,970.36 |
Fool.co.ukThe Dechra share price holds a lesson for all investors!
The Dechra Pharmaceuticals share price has soared of late. But this writer thinks the reason for that is a timely reminder of some investing wisdom. The post The Dechra share price holds a lesson for all investors! appeared first on The Motley Fool UK.
Yahoo Finance UKTrending tickers: Dechra | Wizz Air | Aviva | Lululemon
The latest investor updates on stocks that are trending on Friday.
BloombergEQT to Buy Dechra for £4.5 Billion After Agreeing Price Cut
(Bloomberg) -- EQT AB agreed to buy UK veterinary drugmaker Dechra Pharmaceuticals Plc for a lowered price of £4.46 billion ($5.6 billion) in what is still the biggest European take-private this year.Most Read from BloombergChina Is Drilling a 10,000-Meter-Deep Hole Into the EarthAmazon Is in Talks to Offer Free Mobile Service to US Prime MembersInside the Making of Redfall, Xbox’s Latest MisfireRich Latin Americans Transform Laid-Back Madrid Into a New MiamiHedge Funds at War for Top Traders Da
- PR Newswire
Pentwater Capital Management LP - Form 8.3 - Dechra Pharmacueticals Plc
Pentwater Capital Management LP - Form 8.3 - Dechra Pharmacueticals Plc
- PR Newswire
Norges Bank - Form 8.3 - Dechra Pharmaceuticals PLC
Norges Bank - Form 8.3 - Dechra Pharmaceuticals PLC
- Reuters
UK's Dechra slumps after profit warning
Dechra, which is in talks with private equity group EQT for a possible 4.63 billion pounds ($5.84 billion) all-cash deal, fell 8.6% in early trade. The impact from de-stocking in the United States had been longer than expected and had a material impact on the third quarter, the company said in a trading statement, but added that there were signs that it was re-bounding.
- PR Newswire
Pentwater Capital Management LP - Form 8.3 - Dechra Pharmaceuticals Plc
Pentwater Capital Management LP - Form 8.3 - Dechra Pharmaceuticals Plc
Fool.co.ukThis UK stock jumped 33% on Friday, but I’m not touching it!
Jon Smith explains why a major UK stock soared in price late last week, but also why it's not a viable investment opportunity, in his opinion. The post This UK stock jumped 33% on Friday, but I’m not touching it! appeared first on The Motley Fool UK.
- PR Newswire
Ninety One UK Ltd - Form 8.3 - Dechra Pharmaceuticals Plc
Ninety One UK Ltd - Form 8.3 - Dechra Pharmaceuticals Plc
- Fool.co.uk
Why is the Dechra Pharmaceuticals share price soaring?
Friday morning saw the Dechra Pharmaceuticals share price soar by over a third. Our writer explains why, and whether he's investing. The post Why is the Dechra Pharmaceuticals share price soaring? appeared first on The Motley Fool UK.
Simply Wall St.Declining Stock and Decent Financials: Is The Market Wrong About Dechra Pharmaceuticals PLC (LON:DPH)?
Dechra Pharmaceuticals (LON:DPH) has had a rough month with its share price down 7.2%. However, stock prices are...
- Simply Wall St.
Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.125
The board of Dechra Pharmaceuticals PLC ( LON:DPH ) has announced that the dividend on 13th of April will be increased...
- Simply Wall St.
Investors in Dechra Pharmaceuticals (LON:DPH) have unfortunately lost 40% over the last year
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you...
- Simply Wall St.
Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Dechra Pharmaceuticals...
- Simply Wall St.
Are Dechra Pharmaceuticals PLC's (LON:DPH) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
It is hard to get excited after looking at Dechra Pharmaceuticals' (LON:DPH) recent performance, when its stock has...
- Simply Wall St.
Quite a few insiders invested in Dechra Pharmaceuticals PLC (LON:DPH) last year which is positive news for shareholders
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
- Simply Wall St.
Dechra Pharmaceuticals (LON:DPH) Has Announced That It Will Be Increasing Its Dividend To £0.3289
Dechra Pharmaceuticals PLC's ( LON:DPH ) dividend will be increasing from last year's payment of the same period to...
- Simply Wall St.
Dechra Pharmaceuticals' (LON:DPH) Shareholders Will Receive A Bigger Dividend Than Last Year
Dechra Pharmaceuticals PLC ( LON:DPH ) will increase its dividend from last year's comparable payment on the 18th of...